TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$93.91+1.70 (+1.84%)
Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%
TransMedics cash
Cash and short-term investments held at the end of each period.
TransMedics's cash was $472.68M at Jun 30, 2026. For fiscal 2025 it was $488.37M, up 44.9% from the year before. The highest annual figure on record is $488.37M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $488.37M | +44.9% |
| FY2024 | Dec 31, 2024 | $337.15M | -14.6% |
| FY2023 | Dec 31, 2023 | $394.81M | +95.8% |
| FY2022 | Dec 31, 2022 | $201.68M | +118.0% |
| FY2021 | Dec 31, 2021 | $92.50M | -26.4% |
| FY2020 | Dec 31, 2020 | $125.60M | +55.6% |
| FY2019 | Dec 28, 2019 | $80.70M | +289.1% |
| FY2018 | Dec 29, 2018 | $20.74M | +66.8% |
| FY2017 | Dec 30, 2017 | $12.44M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $472.68M | +18.0% |
| Q1 FY2026 | Mar 31, 2026 | $461.74M | +48.9% |
| Q4 FY2025 | Dec 31, 2025 | $488.37M | +44.9% |
| Q3 FY2025 | Sep 30, 2025 | $466.17M | +41.2% |
| Q2 FY2025 | Jun 30, 2025 | $400.58M | +10.4% |
| Q1 FY2025 | Mar 31, 2025 | $310.14M | -11.4% |
| Q4 FY2024 | Dec 31, 2024 | $337.15M | -14.6% |
| Q3 FY2024 | Sep 30, 2024 | $330.09M | -22.7% |
| Q2 FY2024 | Jun 30, 2024 | $362.75M | -37.7% |
| Q1 FY2024 | Mar 31, 2024 | $350.22M | +79.3% |
| Q4 FY2023 | Dec 31, 2023 | $394.81M | +95.8% |
| Q3 FY2023 | Sep 30, 2023 | $427.11M | +108.9% |
| Q2 FY2023 | Jun 30, 2023 | $582.21M | +902.1% |
| Q1 FY2023 | Mar 31, 2023 | $195.38M | +171.4% |
| Q4 FY2022 | Dec 31, 2022 | $201.68M | +118.0% |
| Q3 FY2022 | Sep 30, 2022 | $204.50M | +98.7% |
| Q2 FY2022 | Jun 30, 2022 | $58.10M | -48.2% |
| Q1 FY2022 | Mar 31, 2022 | $72.00M | -39.0% |
| Q4 FY2021 | Dec 31, 2021 | $92.50M | -26.4% |
| Q3 FY2021 | Sep 30, 2021 | $102.90M | -22.5% |
| Q2 FY2021 | Jun 30, 2021 | $112.20M | -19.5% |
| Q1 FY2021 | Mar 31, 2021 | $118.10M | +62.7% |
| Q4 FY2020 | Dec 31, 2020 | $125.60M | +55.6% |
| Q3 FY2020 | Sep 30, 2020 | $132.70M | +50.3% |
| Q2 FY2020 | Jun 30, 2020 | $139.40M | +44.9% |
| Q1 FY2020 | Mar 31, 2020 | $72.60M | +494.4% |
| Q4 FY2019 | Dec 28, 2019 | $80.70M | +289.1% |
| Q3 FY2019 | Sep 28, 2019 | $88.30M | +200.4% |
| Q2 FY2019 | Jun 29, 2019 | $96.20M | +175.3% |
| Q1 FY2019 | Mar 30, 2019 | $12.22M | +18.6% |
| Q4 FY2018 | Dec 29, 2018 | $20.74M | +66.8% |
| Q3 FY2018 | Sep 29, 2018 | $29.39M | – |
| Q2 FY2018 | Jun 30, 2018 | $34.94M | – |
| Q1 FY2018 | Mar 31, 2018 | $10.30M | – |
| Q4 FY2017 | Dec 30, 2017 | $12.44M | – |
See a number that looks wrong?